Expression and functional implications of YME1L in nasopharyngeal carcinoma

Fuwei Cheng,Haiping Huang,Shiyao Yin,Ji-Sheng Liu,Peng Sun

DOI: https://doi.org/10.1038/s41419-024-06811-6

2024-06-19

Cell Death and Disease

Abstract:Mitochondria play a crucial role in the progression of nasopharyngeal carcinoma (NPC). YME1L, a member of the AAA ATPase family, is a key regulator of mitochondrial function and has been implicated in various cellular processes and diseases. This study investigates the expression and functional significance of YME1L in NPC. YME1L exhibits significant upregulation in NPC tissues from patients and across various primary human NPC cells, while its expression remains relatively low in adjacent normal tissues and primary nasal epithelial cells. Employing genetic silencing through the shRNA strategy or knockout (KO) via the CRISPR-sgRNA method, we demonstrated that YME1L depletion disrupted mitochondrial function, leading to mitochondrial depolarization, reactive oxygen species (ROS) generation, lipid peroxidation, and ATP reduction within primary NPC cells. Additionally, YME1L silencing or KO substantially impeded cell viability, proliferation, cell cycle progression, and migratory capabilities, concomitant with an augmentation of Caspase-apoptosis activation in primary NPC cells. Conversely, ectopic YME1L expression conferred pro-tumorigenic attributes, enhancing ATP production and bolstering NPC cell proliferation and migration. Moreover, our findings illuminate the pivotal role of YME1L in Akt-mTOR activation within NPC cells, with Akt-S6K phosphorylation exhibiting a significant decline upon YME1L depletion but enhancement upon YME1L overexpression. In YME1L-silenced primary NPC cells, the introduction of a constitutively-active Akt1 mutant (caAkt1, at S473D) restored Akt-S6K phosphorylation, effectively ameliorating the inhibitory effects imposed by YME1L shRNA. In vivo studies revealed that intratumoral administration of YME1L-shRNA-expressing adeno-associated virus (AAV) curtailed subcutaneous NPC xenograft growth in nude mice. Furthermore, YME1L downregulation, concurrent with mitochondrial dysfunction and ATP reduction, oxidative injury, Akt-mTOR inactivation, and apoptosis induction were evident within YME1L-silenced NPC xenograft tissues. Collectively, these findings shed light on the notable pro-tumorigenic role by overexpressed YME1L in NPC, with a plausible mechanism involving the promotion of Akt-mTOR activation.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the expression of YME1L in nasopharyngeal carcinoma (NPC) and its functional significance. Specifically, the research aims to:

1. **Evaluate the expression levels of YME1L in nasopharyngeal carcinoma tissues and cells**: By detecting the mRNA and protein expression levels of YME1L in tumor tissues and normal adjacent tissues of nasopharyngeal carcinoma patients, as well as the expression in nasopharyngeal carcinoma cell lines from different sources.

2. **Explore the functional role of YME1L in nasopharyngeal carcinoma cells**: By gene silencing (using the shRNA strategy) or knockout (using the CRISPR - sgRNA method) of YME1L, study its effects on cell mitochondrial function, cell viability, proliferation, cell cycle progression and migration ability.

3. **Analyze the tumor - promoting mechanism of YME1L in nasopharyngeal carcinoma cells**: Explore how YME1L promotes the activation of the Akt - mTOR signaling pathway to enhance ATP production, thereby promoting the proliferation and migration of nasopharyngeal carcinoma cells.

4. **Verify the role of YME1L in in vivo experiments**: By subcutaneously injecting adeno - associated virus (AAV) expressing YME1L - shRNA into nude mice, observe its effect on the growth of nasopharyngeal carcinoma xenograft tumors, and further analyze the effects of YME1L down - regulation on mitochondrial function, ATP production, oxidative damage, inactivation of the Akt - mTOR signaling pathway and cell apoptosis.

In summary, this study aims to comprehensively reveal the expression characteristics of YME1L in nasopharyngeal carcinoma and its potential mechanisms in tumorigenesis and development, providing a theoretical basis for the development of new treatment strategies targeting YME1L.